It’s not obvious what the best leverage points for money/time are and I haven’t been able to justify the time to look
I’ve spent a bunch of time thinking about this.
Here are some leverage points:
Create opportunities for mainstream politicians to support psychedelics without risking their seats (pushes on the Overton window)
Build infrastructure to help the rollout of MDMA & psilocybin go as well as possible after FDA approval
FDA is likely to approve MDMA therapy for PTSD by 2021, and psilocybin therapy for depression by 2023
Academic research into the effects, mechanisms, and applications of psychedelics (especially cog sci, neuroscience, and psychology)
I recently gave a talk at Harvard about this; I’ll share notes from that talk with anyone who shoots me an email requesting them.
Current theme: default
Less Wrong (text)
Less Wrong (link)
Arrow keys: Next/previous image
Escape or click: Hide zoomed image
Space bar: Reset image size & position
Scroll to zoom in/out
(When zoomed in, drag to pan; double-click to close)
Keys shown in yellow (e.g., ]) are accesskeys, and require a browser-specific modifier key (or keys).
]
Keys shown in grey (e.g., ?) do not require any modifier keys.
?
Esc
h
f
a
m
v
c
r
q
t
u
o
,
.
/
s
n
e
;
Enter
[
\
k
i
l
=
-
0
′
1
2
3
4
5
6
7
8
9
→
↓
←
↑
Space
x
z
`
g
I’ve spent a bunch of time thinking about this.
Here are some leverage points:
Create opportunities for mainstream politicians to support psychedelics without risking their seats (pushes on the Overton window)
Build infrastructure to help the rollout of MDMA & psilocybin go as well as possible after FDA approval
FDA is likely to approve MDMA therapy for PTSD by 2021, and psilocybin therapy for depression by 2023
Academic research into the effects, mechanisms, and applications of psychedelics (especially cog sci, neuroscience, and psychology)
I recently gave a talk at Harvard about this; I’ll share notes from that talk with anyone who shoots me an email requesting them.